What is the formula to calculate the FIB-4 (Fibrosis-4) score?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Calculate FIB-4 Score

The FIB-4 score is calculated using the formula: Age (years) × AST (U/L) / [Platelets (10^9/L) × √ALT (U/L)] 1

Formula Breakdown

The FIB-4 calculation requires four parameters:

  • Age in years
  • AST (aspartate aminotransferase) in U/L
  • ALT (alanine aminotransferase) in U/L
  • Platelet count in 10^9/L

The steps to calculate FIB-4 are:

  1. Multiply the patient's age (in years) by AST value
  2. Calculate the square root of ALT
  3. Multiply the platelet count by the square root of ALT
  4. Divide the result from step 1 by the result from step 3

Interpretation of FIB-4 Results

FIB-4 scores are interpreted using established cutoff values:

  • < 1.3: Low probability of advanced liver fibrosis (negative predictive value of 90%) 1, 2
  • 1.3-2.67: Indeterminate range, may require additional testing 1
  • > 2.67: High probability of advanced liver fibrosis (accuracy of 80%) 1
  • > 3.25: Strongly suggestive of advanced fibrosis (positive predictive value of 65%) 1

Clinical Applications

FIB-4 is widely used for:

  • Non-invasive assessment of liver fibrosis in chronic liver diseases including:
    • Chronic hepatitis B 1
    • Chronic hepatitis C 1
    • Non-alcoholic fatty liver disease (NAFLD) 1

Advantages and Limitations

Advantages:

  • Simple calculation using routine laboratory parameters
  • No additional cost beyond standard blood tests
  • Validated in multiple populations 1
  • Recommended by clinical practice guidelines as a first-line non-invasive test 1, 2

Limitations:

  • Intermediate results may require additional testing such as transient elastography or liver biopsy 1
  • Performance may vary between different liver diseases 1
  • Less accurate than specialized imaging techniques like MR elastography 1

Clinical Recommendations

  • FIB-4 should be used as an initial screening tool for liver fibrosis assessment 1, 2
  • For indeterminate results, consider additional non-invasive tests like transient elastography 1
  • Serial FIB-4 measurements can help monitor fibrosis progression over time 3
  • A FIB-4 score < 1.3 reliably excludes advanced fibrosis with a negative predictive value ≥90% 2

Remember that while FIB-4 is a valuable non-invasive tool, liver biopsy remains the gold standard for definitive assessment of liver fibrosis in cases where non-invasive tests yield inconclusive results or when additional histological information is needed 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Liver Disease Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.